Volume | 125,886 |
|
|||||
News | - | ||||||
Day High | 0.01616 | Low High |
|||||
Day Low | 0.0148 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Xcelerate Inc (QB) | XCRT | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.01505 | 0.0148 | 0.01616 | 0.01595 | 0.017467 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
9 | 125,886 | US$ 0.015359 | US$ 1,933 | - | 0.014 - 0.1356 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:21:36 | 10,000 | US$ 0.01595 | USD |
Xcelerate Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 6.47M | 405.45M | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Xcelerate (QB) News
Date | Time | Source | News Article |
---|---|---|---|
5/10/2024 | 14:01 | Edgar (US Regulatory) | Form 1-U - Current Report Pursuant to Regulation A |
5/06/2024 | 10:55 | Edgar (US Regulatory) | Form 1-U - Current Report Pursuant to Regulation A |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XCRT Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.03055 | 0.03055 | 0.014 | 0.0175793 | 1,046,737 | -0.0146 | -47.79% |
1 Month | 0.034 | 0.0378 | 0.014 | 0.0201975 | 394,397 | -0.01805 | -53.09% |
3 Months | 0.04525 | 0.04525 | 0.014 | 0.0268774 | 212,202 | -0.0293 | -64.75% |
6 Months | 0.04 | 0.06 | 0.014 | 0.0326933 | 150,431 | -0.02405 | -60.13% |
1 Year | 0.051 | 0.1356 | 0.014 | 0.0569153 | 178,789 | -0.03505 | -68.73% |
3 Years | 0.084 | 0.15 | 0.014 | 0.0618369 | 204,973 | -0.06805 | -81.01% |
5 Years | 0.0014 | 0.174 | 0.0007 | 0.0325708 | 746,218 | 0.01455 | 1,039.29% |
Xcelerate (QB) Description
Xcelerate has assembled an internationally recognized team of translational clinicians, engineers and business leaders to identify, acquire, and develop engineering advancements, intellectual property and operating business in, or with applications in medical technology and clinical care. Xcelerate acquires innovation at the engineering / patent level, marries it with appropriate early-stage operational med tech companies and applies it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella. |